141![—————————— CONTRAINDICATIONS ———————— Do not use in patients who have manifested life-threatening immediate hypersensitivity reactions, including anaphylaxis, to the product or its com —————————— CONTRAINDICATIONS ———————— Do not use in patients who have manifested life-threatening immediate hypersensitivity reactions, including anaphylaxis, to the product or its com](https://www.pdfsearch.io/img/8360c3bb82b0b97940032f84d8b17f12.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
142![Package Insert - Kogenate FS w Vial Adapter Package Insert - Kogenate FS w Vial Adapter](https://www.pdfsearch.io/img/aba521ec386e4b5ba720390ee319ade2.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
143![Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized](https://www.pdfsearch.io/img/c3159114dbb91e303a1988e37d8f568c.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
144![Part II3 IB:l Labeling Annotated Part II3 IB:l Labeling Annotated](https://www.pdfsearch.io/img/144bad3c50c90a5d2701b1e88131b3a9.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
145![Centeon Pharma GmbH Humate-Pa, Antihemophilic Factor (Human) New Indication: von Willebrand disease Centeon Pharma GmbH Humate-Pa, Antihemophilic Factor (Human) New Indication: von Willebrand disease](https://www.pdfsearch.io/img/aa186c487fdca17d08973eb36102ec8e.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
146![Antihemophilic Factor (Recombinant) ReFacto Antihemophilic Factor (Recombinant) ReFacto](https://www.pdfsearch.io/img/35cd5d7c2ac54bd39c2784e387bfb33d.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
147![HIGHLIGHTS OF PRESCRIBING INFORMATION HIGHLIGHTS OF PRESCRIBING INFORMATION](https://www.pdfsearch.io/img/9e2655466acdeb4296dd736ca4da9499.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
148![SBA - Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method (rAHF-PFM) (ADVATE) SBA - Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method (rAHF-PFM) (ADVATE)](https://www.pdfsearch.io/img/a9f7e0b9f0aef24c348316fce30cf4bb.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
149![National Survey of Hospital Coagulation Laboratories Form Approved OMB Number[removed]Expiration Date: [removed]This survey is being conducted by Analytical Sciences, Inc. (ASI) for Centers for Disease
National Survey of Hospital Coagulation Laboratories Form Approved OMB Number[removed]Expiration Date: [removed]This survey is being conducted by Analytical Sciences, Inc. (ASI) for Centers for Disease](https://www.pdfsearch.io/img/12ed2e147f7c22513e9611f06075a9b9.jpg) | Add to Reading ListSource URL: wwwn.cdc.govLanguage: English - Date: 2006-11-06 14:32:34
|
---|
150![UDC The Universal Data Collection Program Report on the Universal Data Collection Program January 2014 UDC The Universal Data Collection Program Report on the Universal Data Collection Program January 2014](https://www.pdfsearch.io/img/ec9ce705198d9ec05612b314fce3645d.jpg) | Add to Reading ListSource URL: www.cdc.govLanguage: English - Date: 2014-07-07 13:35:41
|
---|